Infliximab Versus Vedolizumab in Outpatient Treatment of Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
Joseph, Joel A. [1 ]
Townsend, Matthew J. [2 ]
Somappa, Aakash K. [1 ]
Sack, Jordan [3 ]
Leboeuf, Nicole R. [4 ]
Sharon, Elad [4 ]
Grover, Shilpa [3 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Brigham Canc Ctr, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001029268.66368.a0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S225
引用
收藏
页码：S164 / S165
页数：2
相关论文
共 50 条
  • [41] Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
    Alorfi, Nasser M.
    Alourfi, Mansour Marzouq
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 119 - 127
  • [42] Steroid use in patients with immune checkpoint inhibitor colitis
    Crothers-Stomps, L.
    Mohsen, W.
    Ramaswamy, P. Kakkadasam
    Mason, R.
    Dzienis, M.
    Edwards, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I487 - I488
  • [43] Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis
    Bishu, Shrinivas
    Melia, Joanna
    Sharfman, William
    Lao, Christopher D.
    Fecher, Leslie A.
    Higgins, Peter D. R.
    GASTROENTEROLOGY, 2021, 160 (03) : 932 - +
  • [44] Immune checkpoint inhibitor colitis with concurrent cytomegalovirus reactivation
    Au, Minnie
    Rajagopalan, Arvind
    Tee, Derrick
    Philpott, Hamish
    INTERNAL MEDICINE JOURNAL, 2022, 52 (03) : 504 - 505
  • [45] Steroid use in patients with immune checkpoint inhibitor colitis
    Crothers-Stomps, L.
    Mohsen, W.
    Ramaswamy, P. Kakkadasam
    Mason, R.
    Dzienis, M.
    Edwards, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I487 - I488
  • [46] Management of Severe Immune Checkpoint Inhibitor Related Colitis
    Khan, Imran
    Belkovsky, Mikhael
    Almadi, Faris S.
    Stockheim, Jessica
    Ulkucu, Attila
    Kanters, Arielle
    Liska, David
    Mitchem, Jonathan B.
    Holubar, Stefan D.
    Valente, Michael A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S114 - S115
  • [47] INFLIXIMAB TREATMENT FOR CHECKPOINT INHIBITOR INDUCED COLITIS: CLINICAL OUTCOMES FROM A MULTI-CENTRE STUDY
    Alexander, James L.
    Sheth, Bhavisha
    Ibraheim, Hajir
    Little, Jessica
    Khan, Muhammad S.
    Richards, Camellia
    Hunter, Nikki
    Mchugh, Kathleen
    Ratnakumaran, Raguprakash
    Nathan, Paul
    Choy, Julia
    Crusz, Shanthini M.
    Furness, Andrew
    Turajlic, Samra
    Pickering, Lisa
    Larkin, James
    Pinato, David
    Papa, Sophie
    Speight, Ally
    Sharma, Anand
    Powell, Nick
    GASTROENTEROLOGY, 2021, 160 (06) : S26 - S27
  • [48] Immune Checkpoint Inhibitor Colitis: Resident Memory Unleashed
    Dougan, Michael
    GASTROENTEROLOGY, 2021, 161 (04) : 1106 - 1108
  • [49] Treatment of steroid-refractory immune checkpoint inhibitor induced intestinal pseudo obstruction with infliximab
    Dai, Cong
    Huang, Yu-Hong
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (07) : 383 - 384
  • [50] Immune-mediated colitis after immune checkpoint inhibitor therapy
    Giesler, Sophie
    Riemer, Roxane
    Lowinus, Theresa
    Zeiser, Robert
    TRENDS IN MOLECULAR MEDICINE, 2025, 31 (03) : 265 - 280
12345